Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article NeonMind Announces Grants Pursuant to Stock Option Plan

NeonMind Announces Grants Pursuant to Stock Option Plan

  • Post published:January 11, 2021
  • Post category:Press Release
Read more about the article NeonMind Appoints Trevor Millar as Chief Psychedelic Officer

NeonMind Appoints Trevor Millar as Chief Psychedelic Officer

  • Post published:January 7, 2021
  • Post category:Press Release
Read more about the article NeonMind Commences Trading Under CSE Ticker Symbol “NEON”

NeonMind Commences Trading Under CSE Ticker Symbol “NEON”

  • Post published:January 4, 2021
  • Post category:Press Release
Read more about the article BetterPlant Subsidiary NeonMind Closes Oversubscribed Initial Public Offering and Exercise in Full of the Agent’s Over-Allotment Option

BetterPlant Subsidiary NeonMind Closes Oversubscribed Initial Public Offering and Exercise in Full of the Agent’s Over-Allotment Option

  • Post published:December 31, 2020
  • Post category:Press Release
Read more about the article Better Plant’s Subsidiary Neonmind to Complete Fully Subscribed IPO and Commence Trading on Monday, January 4, 2021 under the Symbol NEON

Better Plant’s Subsidiary Neonmind to Complete Fully Subscribed IPO and Commence Trading on Monday, January 4, 2021 under the Symbol NEON

  • Post published:December 29, 2020
  • Post category:Press Release
Read more about the article NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss

NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss

  • Post published:November 19, 2020
  • Post category:Press Release
Read more about the article NeonMind Obtains Health Canada Approval to Advance Psilocybin Research

NeonMind Obtains Health Canada Approval to Advance Psilocybin Research

  • Post published:November 12, 2020
  • Post category:Press Release
Read more about the article NeonMind Manufactures 4 Superfood Mushroom Coffees

NeonMind Manufactures 4 Superfood Mushroom Coffees

  • Post published:October 27, 2020
  • Post category:Press Release
Read more about the article NeonMind Superfood Mushroom Coffee Update

NeonMind Superfood Mushroom Coffee Update

  • Post published:October 20, 2020
  • Post category:Press Release
Read more about the article Better Plant Sciences Subsidiary NeonMind Signs Psilocybin Supply Agreement for Clinical Trials

Better Plant Sciences Subsidiary NeonMind Signs Psilocybin Supply Agreement for Clinical Trials

  • Post published:September 29, 2020
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More